Saturn V Capital Management LP
Source: SEC Form 13F · as of Mar 2026Saturn V Capital Management LP holds 14 biotech & pharma companies tracked by BioSniper, totaling $412.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$412.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALUMIS INC. (ALMS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALMSALUMIS INC. | 3,202,075 | $70.5M |
| ABVXAbivax SA | 542,696 | $60.4M |
| PCVXVaxcyte, Inc. | 824,532 | $47.9M |
| PHVSPharvaris N.V. | 1,201,402 | $33.9M |
| IMMXImmix Biopharma, Inc. | 3,693,585 | $33.6M |
| JAZZJazz Pharmaceuticals plc | 162,961 | $30.8M |
| IRONDisc Medicine, Inc. | 449,926 | $28.8M |
| XFORX4 Pharmaceuticals, Inc | 6,456,646 | $26.7M |
| COGTCogent Biosciences, Inc. | 626,635 | $24.1M |
| IVVDInvivyd, Inc. | 10,949,084 | $14.2M |
| CADLCandel Therapeutics, Inc. | 2,896,588 | $14.2M |
| OCSOculis Holding AG | 516,761 | $13.7M |
| OVIDOvid Therapeutics Inc. | 4,166,666 | $9.2M |
| ZURAZura Bio Ltd | 739,960 | $4.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.